Primary CNS Tumor
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors (NCT02502708) | NewLink Genetics Corporation | 2015-10-01 |
Track Primary CNS Tumor automatically
Every clearance here is in the API, with alerts when new ones post.